Nilesh Pandey
Overview
Explore the profile of Nilesh Pandey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur H, Pandey N, Chandaluri L, Shaaban N, Martinez A, Kidder E, et al.
Exp Neurol
. 2025 Feb;
386:115181.
PMID: 39914641
Patients with chronic kidney disease (CKD) are at a significantly increased risk of stroke and experience worse stroke outcomes and higher mortality. CKD exacerbates stroke risk and severity through a...
2.
Bera J, Raj A L, Kumar H, Pandey N, Patel D
Arch Microbiol
. 2024 Nov;
206(12):454.
PMID: 39495262
No abstract available.
3.
Das S, Finney A, Anand S, Rohilla S, Liu Y, Pandey N, et al.
Nat Metab
. 2024 Sep;
6(10):1939-1962.
PMID: 39333384
The incidence of metabolic dysfunction-associated steatohepatitis (MASH) is on the rise, and with limited pharmacological therapy available, identification of new metabolic targets is urgently needed. Oxalate is a terminal metabolite...
4.
Pandey N, Anand S, Kaur H, Richard K, Chandaluri L, Butler M, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3572-3580.
PMID: 39306095
Background: Patients with metabolic dysfunction-associated steatohepatitis (MASH) are at an increased risk of developing venous thromboembolic events, including deep vein thrombosis (DVT). To date, the study of DVT in MASH...
5.
Bera J, Raj A L, Kumar H, Pandey N, Patel D
Arch Microbiol
. 2024 Aug;
206(9):369.
PMID: 39110213
The RNA-based study provides an excellent indication of an organism's gene expression profile. Obtaining high-yield and high-purity RNA from Gram-positive and acid-fast bacteria is difficult without high-end kits and facilities....
6.
Patel P, Thakkar K, Shah D, Shah U, Pandey N, Patel J, et al.
Arch Physiol Biochem
. 2024 Apr;
130(6):886-897.
PMID: 38588401
Context: Peripheral neuropathy (PN) is a multifaceted complication characterized by nerve damage due to oxidative stress, inflammatory mediators, and dysregulated metabolic processes. Early PN manifests as sensory changes that develop...
7.
Pandey N, Kaur H, Chorawala M, Anand S, Chandaluri L, Butler M, et al.
Blood Adv
. 2024 Mar;
8(9):2104-2117.
PMID: 38498701
Venous thromboembolic events are significant contributors to morbidity and mortality in patients with stroke. Neutrophils are among the first cells in the blood to respond to stroke and are known...
8.
Pandey N, Kaur H, Chandaluri L, Anand S, Chokhawala H, Magdy T, et al.
bioRxiv
. 2024 Jan;
PMID: 38260582
Background: Neutrophil-mediated persistent inflammation and neutrophil extracellular trap formation (NETosis) promote deep vein thrombosis (DVT). CD14, a co-receptor for toll-like receptor 4 (TLR4), is actively synthesized by neutrophils, and the...
9.
Tripathi N, Parmar A, Pandey N, Bhardwaj N, Chakrabarty S, Sarkar R, et al.
Chem Biodivers
. 2024 Jan;
21(2):e202301841.
PMID: 38226737
Psoralea corylifolia (syn. Cullen corylifolium), commonly called bawachi, is a medicinal plant extensively used for skin conditions like leukoderma, vitiligo, and psoriasis. It is notably rich in valuable bioactive compounds,...
10.
Dhanesha N, Ansari J, Pandey N, Kaur H, Virk C, Stokes K
Res Pract Thromb Haemost
. 2023 Jun;
7(4):100170.
PMID: 37274177
Patients with acute ischemic stroke are at a high risk of venous thromboembolism (VTE), such as deep vein thrombosis (DVT), estimated to affect approximately 80,000 patients with stroke each year...